FindTrial
Sign In

Non-small cell lung cancer postoperative circulating tumor cells and prognosis clinical research

Non-small cell lung cancer postoperative quantitative monitoring of circulating tumor cells and prognosis clinical research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-13004249
Enrollment
Unknown
Registered
2013-10-23
Start date
2013-08-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Gold Standard:
Index test:

Sponsors

Capital Medical University, Beijing Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) the purpose and content of the research-informed and signed consent; (2) Aged 18-70 years old; (3) diagnosis of non-small cell lung cancer; (4) cTNM staging I-II a period of no surgical contraindications.

Exclusion criteria

Exclusion criteria: (1) pTNM staging III b-IV stage; (2) can not follow the research programs or research programs, can not adhere to complete two years of follow-up review of patients; (3) accompanied by severe systemic disease, the researchers believe will lead to the patient is unable to complete the examination; (4) receiving chemotherapy before surgery or other systemic anti-tumor patients; (5) of the patients had received radiotherapy; (6) 5 years other types of cancer diagnosed.

Design outcomes

Primary

MeasureTime frame
Circulating tumor cell;Tumor free survival;—

Secondary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactZhou Shijie

Capital Medical University, Beijing Chest Hospital

jieyansuo20032006@aliyun.com+86 13683512419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026